摘要:
The invention relates to novel pteridines which can be used in the treatment of respiratory or gastrointestinal complaints or diseases, joint, skin or eye inflammatory diseases, diseases of the periphery or central nervous system or cancer. The invention also relates to pharmaceutical compositions which contain said compounds.
摘要:
The invention relates to novel pteridines which can be used in the treatment of respiratory or gastrointestinal complaints or diseases, joint, skin or eye inflammatory diseases, diseases of the periphery or central nervous system or cancer. The invention also relates to pharmaceutical compositions which contain said compounds.
摘要:
The invention relates to novel pteridines, which are suitable for treating respiratory tract or gastro-intestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system, or carcinomas. The invention also relates to pharmaceutical compositions containing said compounds.
摘要:
The invention relates to novel pteridines which are suitable for treating respiratory or gastrointestinal complaints or diseases, joint, skin or eye inflammatory diseases, disease of the periphery or central nervous system or cancer. The invention also relates to pharmaceutical compositions containing said compounds.
摘要:
This invention relates to compounds of formula (I), their use as inhibitors of the microsomal prostaglandin E 2 synthase-1 (mPGES-1), pharmaceutical compositions containing them, and their use as medicaments for the 10 treatment and/or prevention of inflammatory diseases and associated conditions. A, M, W, R 1 , R 2 , R 3 , R 4 , R 6 , R 2 ,R 7 , R 8 , R 9 , R a , R b have meanings given in the description.